Mounjaro Gains FDA Approval to Reduce Heart Event Risk in Type 2 Diabetes Patients
Eli Lilly's drug, previously approved for diabetes and weight loss, is now indicated to lower the risk of cardiovascular events for individuals with Type 2 diabetes.
Eli Lilly's drug, previously approved for diabetes and weight loss, is now indicated to lower the risk of cardiovascular events for individuals with Type 2 diabetes.
A study indicates that a single dose of CRISPR gene-editing therapy can significantly lower LDL and triglyceride levels for up to a year, potentially offering an alternative to daily medication.
The FDA has reclassified a recall of Taylor Farms de Mexico produce linked to a cyclospora parasite outbreak to its most severe risk level, indicating a potential for serious health consequences or death.
The author shares her personal journey of being diagnosed with ADHD as an adult, detailing how the condition impacted her experience of motherhood and the societal pressures faced by mothers with ADHD.
New research and personal accounts highlight how undiagnosed ADHD symptoms can intensify postpartum, leading to diagnoses years after childbirth.
Research from Sweden indicates that while overall autism diagnoses have surged dramatically, the number of individuals with severe autism and intellectual disabilities has remained consistent.
A long-time sufferer shares her experiences with cold sores, highlighting the emotional toll and available management options.
For decades, cold sores have been a source of shame for millions, but understanding the virus and exploring treatment options can help combat the stigma.
The fastest-growing Ebola outbreak in history has expanded to two new health zones in the eastern Democratic Republic of Congo, with officials concerned about its unprecedented speed and the difficult conditions fueling its spread.